Abbott’s plans to aid diabetes research if elected

NewsGuard 100/100 Score

Opposition Leader Tony Abbott announced last Saturday that he would be rolling out a $35 million funding for a clinical trial network (CTN) to improve the health of Australians with diabetes if he is elected as Prime Minister. The Rudd Governments $5million to the CTN will be supplemented by these funds. “This is one Coalition commitment I would be very happy for the government to match,” he said.

A CTN would provide faster access to new therapies and technologies for diabetics. Opposition health spokesman Peter Dutton revealed that about 153 clinical trials are conducted overseas compared to just nine in Australia. He said, “If we are able to give the opportunity to hundreds, if not thousands of children, to see a brighter way forward then I think that's a great outcome for our country…We do have the ultimate goal of wanting to find a cure but in the interim we want to find ways in which we can support kids and their mums and dads who worry anxiously every night.”

Reports reveal that Australia has some of the highest rates of type 1 diabetes in the world. Type 1 diabetes typically starts early sometimes even in childhood and needs to be treated with daily injections of insulin. Around 140,000 Australians have type 1 diabetes, while over 800,000 suffer from both forms i.e. types 1 and 2.

According to Juvenile Diabetes Research Foundation chief executive Mike Wilson, “We want the best Australian science to move out of the laboratory and into the clinic. This clinical trial network will also help bring international trials to Australia.” He promised that the Foundation will be contributing a further $10 million towards the program.

Mr. Abbott emphasized that this was no political gimmick saying, “I think this is a good cause. I don't think this is a party political issue, I think this is something all of us want to see progressed…I very much hope that despite the fiscal stringency the Government might see its way clear to match this commitment from the Coalition.”

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2020, April 03). Abbott’s plans to aid diabetes research if elected. News-Medical. Retrieved on May 04, 2024 from https://www.news-medical.net/news/20100704/Abbotts-plans-to-aid-diabetes-research-if-elected.aspx.

  • MLA

    Mandal, Ananya. "Abbott’s plans to aid diabetes research if elected". News-Medical. 04 May 2024. <https://www.news-medical.net/news/20100704/Abbotts-plans-to-aid-diabetes-research-if-elected.aspx>.

  • Chicago

    Mandal, Ananya. "Abbott’s plans to aid diabetes research if elected". News-Medical. https://www.news-medical.net/news/20100704/Abbotts-plans-to-aid-diabetes-research-if-elected.aspx. (accessed May 04, 2024).

  • Harvard

    Mandal, Ananya. 2020. Abbott’s plans to aid diabetes research if elected. News-Medical, viewed 04 May 2024, https://www.news-medical.net/news/20100704/Abbotts-plans-to-aid-diabetes-research-if-elected.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Increased emotional sensitivity linked to previous COVID-19 infection, new research suggests